Search Results - Terol Casterá, M.

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Prognostic impact of “MYC/BCL‐2 double expressors” in diffuse large B‐cell lymphoma

    Prognostic impact of “MYC/BCL‐2 double expressors” in diffuse large B‐cell lymphoma by Ferrer Lores, B., Navarro Cubells, B., Teruel Casasús, A., Garcia Sanchís, L., Serrano Alcalá, A., Pastor Galán, I., Morello Gonzalez, D., Martinez Ciarpaglini, C., Amat, P., Melia Prades, M., Rodriguez Ramirez, M., Ferrandez Izquierdo, A., Terol Casterá, M.

    Published in Hematological oncology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF OBINUTUZUMAB BENDAMUSTINE TREATMENT IN PATIENTS WITH RELAPSED /REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

    A PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF OBINUTUZUMAB BENDAMUSTINE TREATMENT IN PATIENTS WITH RELAPSED /REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA by García‐Marco, J., Baltasar Tello, P., Gonzalez Garcia, E., Ríos Herranz, E., Ramírez Payer, Á., Terol Castera, M., Champ, D., Medina Pérez, Á., Gironella Mesa, M., Rodríguez Fernández, A., Muntañola Prat, A., Suárez Cabrera, A., Puerta Puerta, J., Fernández Zarzoso, M., Rodríguez Calvillo, M., Clavel Piá, J., Dourdil Sahun, V., Ferrá Coll, C., Pérez Persona, E., Marrero Santos, C., Forés Cachón, R., Delgado González, J.

    Published in Hematological oncology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy

    Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previou... by Mei, Matthew G., Corazzelli, Gaetano, Morschhauser, Frank, Phillips, Elizabeth, Collins, Graham P., Lee, Hun Ju, Ansell, Steve M, Moskowitz, Craig H., Johnson, Nathalie A., Kuruvilla, John, Hutchings, Martin, Terol Castera, María José, Hawkins, George, Vossenkaemper, Anna, Collins, Teresa, Lesley, Robin, Dean, Emma, Yu, Ting, Hall, Connor, Cerec, Virginie, Zinzani, Pier Luigi

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

    Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leuk... by Garcia-Marco, Jose, Baltasar Tello, Patricia, Garcia, Esther González, Ríos Herranz, Eduardo, Ramirez Payer, Angel, Terol Castera, María José, Champ, Diana, Medina Perez, Angeles, Gironella, Mercedes, Rodríguez Fernández, Alicia, Muntañola Prat, Ana, Suárez Cabrera, Alexia, Jurado Chacón, Manuel, Fernández Zarzoso, Miguel, Rodríguez, Mercedes, Clavel, Juana, Dourdil Sahun, Maria Victoria, Ferra Coll, Christelle M, Pérez Persona, Ernesto, Marrero Santos, Carmen Milagros, Forés, Rafael, Delgado, Julio

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: